Abnormal neurotransmissions in the mesolimbic dopamine pathway contribute to the pathophysiology of schizophrenia, while the blockade of dopamine D2 receptor (D2R) activity in the mesolimbic pathway is the main mechanism of antipsychotic drug action [15,16,17]. The gene discussed is DRD2; the disease is schizophrenia.